Dexmedetomidine 3 (DrugBank: Dexmedetomidine)
1 disease告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
280 | 巨大動静脈奇形(頚部顔面又は四肢病変) | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02552459 (ClinicalTrials.gov) | September 2015 | 26/5/2015 | Effect of Dexmedetomidine Combined With Sufentanil for Postoperative Intravenous Analgesia in Neurosurgery | Effect of Dexmedetomidine Combined With Sufentanil for Postoperative Intravenous Analgesia in Neurosurgery: A Randomized Controlled Study | Arteriovenous Malformation | Drug: Sufentanil;Drug: dexmedetomidine 1;Drug: dexmedetomidine 2;Drug: dexmedetomidine 3 | First Affiliated Hospital, Sun Yat-Sen University | NULL | Recruiting | 18 Years | 65 Years | Both | 120 | Phase 4 | China |